The global CGT market is expected to reach sales of $76.03 billion by 2030, at a CAGR of 44%, driven by gene-modified cell therapies and gene therapies. The development of CGTs in oncology is ...
The global CGT market is expected to reach sales of $76.03 billion by 2030, at a CAGR of 44%, driven by gene-modified cell therapies and gene therapies. The development of CGTs in oncology is still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback